Presence of Antitopoisomerase I Antibody Alone May Not Be Sufficient for the Diagnosis of Systemic Sclerosis

REFERENCES

1. 1.↵
   1. van den Hoogen F,
   2. Khanna D,
   3. Fransen J,
   4. Johnson SR,
   5. Baron M,
   6. Tyndall A,
   7. et al.

   2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65: 2737–47.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Johnson SR,
   2. Soowamber ML,
   3. Fransen J,
   4. Khanna D,
   5. Van Den Hoogen F,
   6. Baron M,
   7. et al.

   There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol 2018;47:62–70.

   OpenUrl
3. 3.↵
   1. Cepeda EJ,
   2. Reveille JD

   . Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 2004;16:723–32.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Gabrielli A,
   2. Avvedimento EV,
   3. Krieg T

   . Scleroderma. N Engl J Med 2009;360:1989–2003.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Patterson KA,
   2. Roberts-Thomson PJ,
   3. Lester S,
   4. Tan JA,
   5. Hakendorf P,
   6. Rischmueller M,
   7. et al.

   Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis. Arthritis Rheumatol 2015;67:3234–44.

   OpenUrl
6. 6.↵
   1. Nandiwada SL,
   2. Peterson LK,
   3. Mayes MD,
   4. Jaskowski TD,
   5. Malmberg E,
   6. Assassi S,
   7. et al.

   Ethnic differences in autoantibody diversity and hierarchy: more clues from a US cohort of patients with systemic sclerosis. Rheumatol 2016;43:1816–24.

   OpenUrl
7. 7.↵
   1. Jarzabek-Chorzelska M,
   2. Blaszczyk M,
   3. Jablonska S,
   4. Chorzelski T,
   5. Kumar V,
   6. Beutner EH

   . Scl-70 antibody—a specific marker of systemic sclerosis. Brit J Dermatol 1986;115:393–401.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Vazquez-Abad D,
   2. Tian L,
   3. Zanetti M,
   4. Rothfield NF

   . A crossreactive idiotype in scleroderma. Clin Exp Immunol 1997;108:420–7.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Bridges AJ,
   2. Lorden TE,
   3. Havighurst TC

   . Autoantibody testing for connective tissue diseases. Comparison of immunodiffusion, immunoblot, and enzyme immunoassay. Am J Clin Pathol 1997;108:406–10.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Albon S,
    2. Bunn C,
    3. Swana G,
    4. Karim Y

    . Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis. J Immunol Methods 2011;365:126–31.

    OpenUrlCrossRefPubMed